Inj, aflibercept-jbvf, 1 mg
Full descriptor
Injection, aflibercept-jbvf (yesafili), biosimilar, 1 mg
Details
- Code
- Q5155
- Short descriptor
- Inj, aflibercept-jbvf, 1 mg
- Code set
- HCPCS Level II
- Release
- July 2026
- Status
- Active
- Added
- Oct 1 2025
Nearby codes
Code sets are published in blocks, so neighbours are usually related.
Inj, omlyclo, 5 mg
Inj, tocilizumab-anoh, 1 mg
Inj, aflibercept-yszy, 1 mg
Inj, denosumab-bmwo, 1 mg
Inj, denosumab-bnht, 1 mg
Inj, eculizumab-aeeb, 2 mg
Inj, denosumab-dssb, 1 mg
Inj, eculizumab-aagh, 2 mg
Sources
- CMS HCPCS Level II — July 2026, public domain
Reference information only. Not billing advice. Verify against the payer before you file.